Watching Veru; Traders Circulate Analyst Comments Suggesting Co Could See A Take Out From Large Pharma Due To Effectivr GLP-1; Gives It An Outperform Rating And $3 PT
Watching Veru; Traders Circulate Analyst Comments Suggesting Co Could See A Take Out From Large Pharma Due To Effectivr GLP-1; Gives It An Outperform Rating And $3 PT
觀看 Veru；交易員散佈分析師的評論，暗示由於有效的 GLP-1，該公司可能會從大型製藥公司中脫穎而出；給予其跑贏大盤評級和3美元
Watching Veru; Traders Circulate Analyst Comments Suggesting Co Could See A Take Out From Large Pharma Due To Effectivr GLP-1; Gives It An Outperform Rating And $3 PT
觀看 Veru；交易員散佈分析師的評論，暗示由於有效的 GLP-1，該公司可能會從大型製藥公司中脫穎而出；給予其跑贏大盤評級和3美元
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。